Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Impact of sirolimus on early graft function after deceased-donor kidney transplantation.

McTaggart RA, Tomlanovich SJ, Feng S.

Transplantation. 2005 Apr 27;79(8):991; author reply 991-2. No abstract available.

PMID:
15849562
2.

Sirolimus impairs improvement of the gonadal function after renal transplantation.

Tondolo V, Citterio F, Panocchia N, Nanni G, Castagneto M.

Am J Transplant. 2005 Jan;5(1):197. No abstract available.

3.

Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.

Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.

Nephrology (Carlton). 2008 Feb;13(1):80-6. doi: 10.1111/j.1440-1797.2007.00866.x.

PMID:
18199109
4.

Rapamycin enhances lifespan: at last, an advantage for transplant recipients?

Geissler EK.

Nephrol Dial Transplant. 2009 Dec;24(12):3623-5. doi: 10.1093/ndt/gfp496. Epub 2009 Sep 22. No abstract available.

5.

Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.

Stephany BR, Augustine JJ, Krishnamurthi V, Goldfarb DA, Flechner SM, Braun WE, Hricik DE, Dennis VW, Poggio ED.

Transplantation. 2006 Aug 15;82(3):368-74.

PMID:
16906035
6.

Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor.

Durrbach A, Rostaing L, Tricot L, Ouali N, Wolf P, Pouteil-Noble C, Kessler M, Viron B, Thervet E.

Transplantation. 2008 Feb 15;85(3):486-90. doi: 10.1097/TP.0b013e318160d3c9.

PMID:
18301342
7.

Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.

Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J; RAD A2420 Study Group.

Transplantation. 2009 Jul 15;88(1):69-76. doi: 10.1097/TP.0b013e3181aa7d87.

PMID:
19584683
9.

[Clinical effect of induction therapy with monoclonal antibodies after deceased-donor kidney transplantation (an experience from Vilnius Center)].

Rainiene T, Dobrovolskiene R, Dainys B, Kucinskis G, Zelvys A.

Medicina (Kaunas). 2007;43 Suppl 1:109-13. Lithuanian.

10.

The evolving role of sirolimus in renal transplantation.

Dupont P, Warrens AN.

QJM. 2003 Jun;96(6):401-9. Review. No abstract available.

11.

Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.

Foley DP, Patton PR, Meier-Kriesche HU, Li Q, Shenkman B, Fujita S, Reed A, Hemming AW, Kim RD, Howard RJ.

Clin Transpl. 2005:101-9.

PMID:
17424728
12.

Donor pretreatment as an adjunct to cadaveric renal transplantation--update 1979.

Guttmann RD, Morehouse DD, Meakins JL, Milne CA, Knaack J.

Transplant Proc. 1980 Jun;12(2):341-7. No abstract available.

PMID:
6994304
13.

Sirolimus use in recipients of expanded criteria donor kidneys.

House AA, Nguan CY, Luke PP.

Drugs. 2008;68 Suppl 1:41-9. Review.

PMID:
18442300
14.

Recovery of graft function early posttransplant determines long-term graft survival in deceased donor renal transplants.

Hassanain M, Tchervenkov JI, Cantarovich M, Metrakos P, Paraskevas S, Keith D, Baran D, Fernandez M, Mangel R, Chaudhury P.

Transplant Proc. 2009 Jan-Feb;41(1):124-6. doi: 10.1016/j.transproceed.2008.10.046.

PMID:
19249494
15.

Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.

Boratynska M, Banasik M, Patrzalek D, Klinger M.

Exp Clin Transplant. 2008 Mar;6(1):59-66.

16.

[Delayed graft function and its impact on the antigraft response after cadaver kidney transplantation].

Rainiene T, Asakiene E, Zelvys A, Dainys B.

Medicina (Kaunas). 2005;41 Suppl 1:101-6. Lithuanian.

17.

Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors.

Hassanain M, Tchervenkov J, Cantarovich M, Metrakos P, Paraskevas S, Keith D, Baran D, Fernandez M, Mangel R, Chaudhury P.

Transplant Proc. 2009 Jan-Feb;41(1):133-4. doi: 10.1016/j.transproceed.2008.10.044.

PMID:
19249497
18.

Kidneys from deceased donors more than 75 years perform acceptably after transplantation.

Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jørgensen PF, Scholz T, Midtvedt K.

Transplantation. 2009 May 27;87(10):1437-41. doi: 10.1097/TP.0b013e3181a4ebd2.

PMID:
19461478
19.
20.

Sirolimus conversion experience in a single center.

Wang HH, Huang JY, Chu SH, Chiang YJ, Liu KL, Lai PC.

Transplant Proc. 2008 Sep;40(7):2209-10. doi: 10.1016/j.transproceed.2008.07.052.

PMID:
18790194
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk